ArticleFrontiers in pharmacology2025
Differential carbon source utilization drives metabolic state and resuscitation in antibiotic-tolerant persister cells.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bacterial Persister Cells as Evolutionary Catalysts of Antibiotic Resistance: Mechanisms, Clinical Implications, and Therapeutic Strategies.Antibiotics (Basel, Switzerland) · 2026Review
- Sequential eradication of bacterial persisters: integrating phytochemical pharmacology with microenvironment-responsive delivery strategies.Frontiers in microbiology · 2026Review
- (p)ppGpp mediates persister formation inFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Persistent infections remain challenging due to dormant bacterial cells that tolerate conventional antibiotics. Specifically, persister cells, phenotypic variants characterized by high antibiotic tolerance, can resume growth once antibiotic stress is alleviated. While general metabolic traits of persister cells have been documented, the metabolic shifts during persistence and resuscitation remain poorly understood. Methods: We applied stable isotope labeling using Results: The results demonstrated major differences in metabolic activities between normal and persister cells. Compared to normal cells, persister cells exhibited reduced metabolism. Peripheral pathways including parts of the central pathway, the pentose phosphate pathway, and the tricarboxylic acid (TCA) cycle, exhibited delayed labeling dynamics in persister cells. Proteinogenic amino acid profiling further demonstrated generalized but reduced labeling in persisters when using glucose as the sole carbon source, indicating a uniform slowdown in protein synthesis. Under acetate conditions, persister cells exhibited a more substantial metabolic shutdown, with markedly reduced labeling across nearly all pathway intermediates and amino acids. This reduction is likely due to substrate inhibition coupled with ATP demands required to activate acetate for central metabolism. Discussion: These findings help improve the understanding of bacterial persistence by demonstrating that persister cell metabolism adapts to available carbon sources. These insights into persister metabolism may inform the development of targeted strategies to more effectively combat persistent bacterial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.